Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171997 | SCV000051399 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038736 | SCV000062414 | likely benign | not specified | 2018-02-02 | criteria provided, single submitter | clinical testing | p.Gln512Pro in exon 12 of LDB3: This variant is not expected to have clinical si gnificance because it has been identified in 0.29% of Finnish chromosomes by the Genome Aggregation Database (gnomAD; http://gnomad.broadinstitute.org; dbSNP rs 138951890). Computational tools predict that this variant impacts protein functi on but this evidence is insufficient to override the high minor allele frequency . ACMG/AMP Criteria applied: BS1, PP3 |
Gene |
RCV000171997 | SCV000236004 | benign | not provided | 2021-04-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24503780, 27896284, 20474083, 23861362, 17097056, 30847666) |
Invitae | RCV000988403 | SCV000581399 | likely benign | Myofibrillar myopathy 4 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000171997 | SCV000700770 | uncertain significance | not provided | 2017-03-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619692 | SCV000737327 | likely benign | Cardiovascular phenotype | 2019-04-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000623075 | SCV000740593 | uncertain significance | Primary familial dilated cardiomyopathy | 2016-08-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988403 | SCV001138108 | benign | Myofibrillar myopathy 4 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000171997 | SCV001150626 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | LDB3: BP4 |
CHEO Genetics Diagnostic Laboratory, |
RCV001170178 | SCV001332728 | benign | Cardiomyopathy | 2018-01-22 | criteria provided, single submitter | clinical testing | |
Cytogenetics- |
RCV001293341 | SCV001481929 | likely benign | Dilated cardiomyopathy 1C | 2014-08-16 | no assertion criteria provided | case-control |